LA JOLLA INSTITUTE FOR IMMUNOLOGY: Form 990, tax year 2017
View the entire original 990 at ProPublica ↗
- Organization
- LA JOLLA INSTITUTE FOR IMMUNOLOGY (EIN 33-0328688)
- Tax period
- 2017-01-01 to 2017-12-31
- Filed
- 2018-11-15
- IRS object ID
- 201843199349302599
- Schema version
- 2017v2.3
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule D
- Schedule F
- Schedule I
- Schedule J
- Schedule L
- Schedule O
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2018-11-15T09:01:07-06:00 | ReturnTs |
| Tax Period End | 2017-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 861065772 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Deloitte Tax LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 695 Town Center Drive Suite 1200 | AddressLine1Txt |
| City | Costa Mesa | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 926261924 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2017-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 330328688 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | La Jolla Institute for Allergy | BusinessNameLine1Txt |
| Business Name Line2 | & Immunology | BusinessNameLine2Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | LAJO | BusinessNameControlTxt |
| Phone | 8587526500 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 9420 Athena Circle | AddressLine1Txt |
| City | La Jolla | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 920371387 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | Jennifer Keyes | PersonNm |
| Person Title | CFO | PersonTitleTxt |
| Phone | 8587526500 | PhoneNum |
| Signature | 2018-11-15 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | John Sadoff Jr | PreparerPersonNm |
| PTIN | P00540589 | PTIN |
| Phone | 7144367100 | PhoneNum |
Filing Security Information FilingSecurityInformation
IP Address IPAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| I Pv4 Address | 167.219.48.58 | IPv4AddressTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IP | 2018-11-15 | IPDt |
| IP Tm | 02:29:19 | IPTm |
| IP Timezone | US | IPTimezoneCd |
| Filing License Type | P | FilingLicenseTypeCd |
| At Submission Creation Device Id | BBC6FF48F749624228983DC5C77016F783C914CC | AtSubmissionCreationDeviceId |
| At Submission Filing Device Id | CE2E37D982145188185ED530D22A0BCB5FB961D3 | AtSubmissionFilingDeviceId |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2017 | TaxYr |
| Build TS | 2019-02-21 02:37:17Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | Jennifer Keyes | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 9420 Athena Circle | AddressLine1Txt |
| City | La Jolla | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 920371387 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $57,462,019 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | www.lji.org | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1988 | FormationYr |
| Legal Domicile State | CA | LegalDomicileStateCd |
| Activity Or Mission | Biomedical research dedicated to improving human health through studies of the immune system. | ActivityOrMissionDesc |
| Voting Members Governing Body | 25 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 24 | VotingMembersIndependentCnt |
| Total Employee | 418 | TotalEmployeeCnt |
| Total Volunteers | 99 | TotalVolunteersCnt |
| Total Gross UBI | $305,173 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $125,666 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $51,251,936 | PYContributionsGrantsAmt |
| CY Contributions Grants | $49,333,077 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $6,329,766 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $5,797,546 | CYProgramServiceRevenueAmt |
| PY Investment Income | $293,653 | PYInvestmentIncomeAmt |
| CY Investment Income | $885,432 | CYInvestmentIncomeAmt |
| PY Other Revenue | $1,528,905 | PYOtherRevenueAmt |
| CY Other Revenue | $2,014,061 | CYOtherRevenueAmt |
| PY Total Revenue | $59,404,260 | PYTotalRevenueAmt |
| CY Total Revenue | $58,030,116 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $10,000 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $7,000 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $27,887,172 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $30,484,441 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $704,304 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $30,084,309 | PYOtherExpensesAmt |
| CY Other Expenses | $27,785,468 | CYOtherExpensesAmt |
| PY Total Expenses | $57,981,481 | PYTotalExpensesAmt |
| CY Total Expenses | $58,276,909 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $1,422,779 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | -$246,793 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $38,148,822 | TotalAssetsBOYAmt |
| Total Assets EOY | $37,144,519 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $10,525,525 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $9,768,015 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $27,623,297 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $27,376,504 | NetAssetsOrFundBalancesEOYAmt |
| Mission | At La Jolla Institute, our scientists focus on understanding how the immune system works in order to promote human health and prevent disease. Our discoveries apply to many diseases, ranging from diabetes to heart disease, infectious diseases to cancer. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $50,825,367 | ExpenseAmt |
| Grant | $7,000 | GrantAmt |
| Revenue | $5,797,546 | RevenueAmt |
| Desc | The La Jolla Institute for Allergy and Immunology ("LJI") is a private, nonprofit medical research organization that is recognized as a world leader in comprehensive research dedicated to understanding the intricacies and power of the immune system and applying that knowledge toward its goal of Life Without Disease.The Institute is home to 23 independent laboratories, each operated by a leading scientist handpicked for her creativity and pioneering spirit. Each of these labs is dedicated to understanding the far-reaching influence of the immune system and to training to the next generation of scientists, to promote human health and prevent a wide range of diseases. | Desc |
| Total Program Service Expenses | $50,825,367 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | 0 | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Temp Or Permanent Endowments | 0 | TempOrPermanentEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | 0 | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (1) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (1) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | 0 | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | 0 | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | Yes (1) | BusinessRlnWithFamMemInd |
| Business Rln With Officer Ent | Yes (1) | BusinessRlnWithOfficerEntInd |
| Deductible Non Cash Contri | 0 | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | 0 | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 104 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 418 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | Yes (1) | UnrelatedBusIncmOverLimitInd |
| Form990 T Filed | Yes (1) | Form990TFiledInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 25 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 24 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (1) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | 0 | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TX | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | UT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AZ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Jennifer Keyes | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 8587526500 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 9420 Athena Circle | AddressLine1Txt |
| City | La Jolla | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 920371387 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (35 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | OfficerOfficerInd | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|---|
| Pamela W Blakely | |||||||||
| Director | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| Richard S Bodman | |||||||||
| Director | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| Mark V Bowles | |||||||||
| Director | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| David A Brenner MD | |||||||||
| Director | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| Anthony Carr | |||||||||
| Director | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| Kristine Charton JD | |||||||||
| Director | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| Barton J Cohen | |||||||||
| Director | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| Michael D Coit | |||||||||
| Director | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| David Dominguez | |||||||||
| Director | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| Robert C Dynes PhD | |||||||||
| Director | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| Francois Ferre PhD | |||||||||
| Director (Start 02/10/17) | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| Sergio Jinich | |||||||||
| Director (End 04/03/2017) | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| Richard K Kornfeld | |||||||||
| Director | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| Robert W Mahley MD PhD | |||||||||
| Director | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| John E Major | |||||||||
| Director | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| Gail K Naughton PhD | |||||||||
| Director | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| Hiroshi Okazaki PhD | |||||||||
| Director | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| Hunt Pettit | |||||||||
| Director | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| Larry S Spitcaufsky | |||||||||
| Director | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| Thomas L Tullie | |||||||||
| Director | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| David L Steffy | |||||||||
| Director (Start 08/11/17) | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| Fred Wasserman MBA DrPH | |||||||||
| Director | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| David R Webb PhD | |||||||||
| Director | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| Herbert A Wertheim OK DSC | |||||||||
| Director (End 05/19/17) | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| Vanessa V Wertheim PhD MBA RN | |||||||||
| Director (Start 05/19/17) | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| Eric V Zwisler | |||||||||
| Director | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| Mitchell Kronenberg PhD | |||||||||
| President & CSO | 40.00 | 0.00 | Yes (X) | $523,837 | $0 | $59,515 | Yes (X) | ||
| Jennifer K Keyes | |||||||||
| CFO | 40.00 | 0.00 | $175,019 | $0 | $35,925 | Yes (X) | |||
| Amnon Altman | |||||||||
| Director, Scientific Affairs | 40.00 | 0.00 | $321,960 | $0 | $63,339 | Yes (X) | |||
| Stephen Wilson | |||||||||
| EVP, Chief Administrative Officer | 40.00 | 0.00 | $355,522 | $0 | $73,630 | Yes (X) | |||
| Hilde Cheroutre | |||||||||
| Division Head/Professor | 40.00 | 0.00 | $278,809 | $0 | $50,180 | Yes (X) | |||
| Klaus Ley | |||||||||
| Division Head/Professor | 40.00 | 0.00 | $344,683 | $0 | $50,161 | Yes (X) | |||
| Stephen P Schoenberger | |||||||||
| Professor | 40.00 | 0.00 | $308,279 | $0 | $69,630 | Yes (X) | |||
| Alessandro Sette | |||||||||
| Center Head/Division Head/Pro | 40.00 | 0.00 | $406,128 | $0 | $66,094 | Yes (X) | |||
| Catherine Hedrick | |||||||||
| Professor | 40.00 | 0.00 | $308,280 | $0 | $57,605 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $3,022,517 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $526,079 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 50 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| Thien Douglas Y | |||||
| 701 Colle e Ave | Menlo Park | CA | 94025 | Consultant to provide services and asses | $310,000 |
| Pillsbury Winthrop Shaw Pittman LLP | |||||
| PO Box 742262 | Los Angeles | CA | 900742262 | Patent Related (Legal and Professional | $220,191 |
| Ho Patrick | |||||
| 2436 Corte Azul | Carlsbad | CA | 92009 | Consulting service | $182,291 |
| 1903 Solutions LLC | |||||
| 2549 Eastbluff Dr Suite 378 | Newport Beach | CA | 92660 | IT Web Support for Forti Analyzer | $126,005 |
| Moss-Adams LLP | |||||
| PO Box 101822 | Pasadena CA | CA | 911891822 | Auditor (audit the Organization's financ | $106,855 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 5 | CntrctRcvdGreaterThan100KCnt |
| Federated Campaigns | $80,000 | FederatedCampaignsAmt |
| Government Grants | $33,928,700 | GovernmentGrantsAmt |
| All Other Contributions | $15,324,377 | AllOtherContributionsAmt |
| Total Contributions | $49,333,077 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | Consortium Revenue | Desc |
| Business | 900099 | BusinessCd |
| Total Revenue Column | $5,797,546 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $5,797,546 | RelatedOrExemptFuncIncomeAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $5,797,546 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $317,335 | TotalRevenueColumnAmt |
| Exclusion | $317,335 | ExclusionAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $756,914 | TotalRevenueColumnAmt |
| Exclusion | $756,914 | ExclusionAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | -$569,735 | SecuritiesAmt |
| Other | $1,638 | OtherAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $569,735 | SecuritiesAmt |
| Other | -$1,638 | OtherAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $568,097 | TotalRevenueColumnAmt |
| Exclusion | $568,097 | ExclusionAmt |
Other Revenue Misc OtherRevenueMiscGrp (3 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | ExclusionExclusionAmt | Unrelated Business RevenueUnrelatedBusinessRevenueAmt |
|---|---|---|---|---|
| Other Income | 900099 | $951,974 | $951,974 | |
| Building Management | 561700 | $267,731 | $267,731 | |
| Technical Services | 541900 | $37,442 | $37,442 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $1,257,147 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $58,030,116 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $5,797,546 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $305,173 | UnrelatedBusinessRevenueAmt |
| Exclusion | $2,594,320 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $7,000 | TotalAmt |
| Program Services | $7,000 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,608,747 | TotalAmt |
| Program Services | $1,415,697 | ProgramServicesAmt |
| Management And General | $167,064 | ManagementAndGeneralAmt |
| Fundraising | $25,986 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $22,233,965 | TotalAmt |
| Program Services | $19,404,728 | ProgramServicesAmt |
| Management And General | $2,767,840 | ManagementAndGeneralAmt |
| Fundraising | $61,397 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,234,805 | TotalAmt |
| Program Services | $1,949,867 | ProgramServicesAmt |
| Management And General | $277,116 | ManagementAndGeneralAmt |
| Fundraising | $7,822 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,828,982 | TotalAmt |
| Program Services | $2,405,140 | ProgramServicesAmt |
| Management And General | $391,910 | ManagementAndGeneralAmt |
| Fundraising | $31,932 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,577,942 | TotalAmt |
| Program Services | $1,376,754 | ProgramServicesAmt |
| Management And General | $195,665 | ManagementAndGeneralAmt |
| Fundraising | $5,523 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $418,176 | TotalAmt |
| Program Services | $372,177 | ProgramServicesAmt |
| Management And General | $45,999 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $205,393 | TotalAmt |
| Management And General | $205,393 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $937,156 | TotalAmt |
| Program Services | $215,546 | ProgramServicesAmt |
| Management And General | $346,748 | ManagementAndGeneralAmt |
| Fundraising | $374,862 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $135,541 | TotalAmt |
| Program Services | $5,051 | ProgramServicesAmt |
| Management And General | $130,490 | ManagementAndGeneralAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $159,447 | TotalAmt |
| Program Services | $123,690 | ProgramServicesAmt |
| Management And General | $9,432 | ManagementAndGeneralAmt |
| Fundraising | $26,325 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,121,151 | TotalAmt |
| Program Services | $828,299 | ProgramServicesAmt |
| Management And General | $285,670 | ManagementAndGeneralAmt |
| Fundraising | $7,182 | FundraisingAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $6,336,188 | TotalAmt |
| Program Services | $5,639,207 | ProgramServicesAmt |
| Management And General | $696,981 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $670,522 | TotalAmt |
| Program Services | $582,972 | ProgramServicesAmt |
| Management And General | $66,928 | ManagementAndGeneralAmt |
| Fundraising | $20,622 | FundraisingAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $197,174 | TotalAmt |
| Program Services | $170,656 | ProgramServicesAmt |
| Management And General | $21,689 | ManagementAndGeneralAmt |
| Fundraising | $4,829 | FundraisingAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,701,880 | TotalAmt |
| Program Services | $1,701,880 | ProgramServicesAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $246,819 | TotalAmt |
| Program Services | $242,806 | ProgramServicesAmt |
| Management And General | $4,013 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Management And GeneralManagementAndGeneralAmt | Program ServicesProgramServicesAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| UBIT taxes | $52,029 | $52,029 | ||
| Lab Supplies & Svcs | $8,001,470 | $181,182 | $7,820,288 | |
| Consortiums | $5,564,371 | $5,564,371 | ||
| Manuscripts Cost | $1,338,350 | $598,813 | $601,713 | $137,824 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $699,801 | TotalAmt |
| Program Services | $397,525 | ProgramServicesAmt |
| Management And General | $302,276 | ManagementAndGeneralAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $58,276,909 | TotalAmt |
| Program Services | $50,825,367 | ProgramServicesAmt |
| Management And General | $6,747,238 | ManagementAndGeneralAmt |
| Fundraising | $704,304 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,267 | BOYAmt |
| EOY | $1,667 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,812,686 | BOYAmt |
| EOY | $3,731,697 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $14,197,357 | BOYAmt |
| EOY | $10,840,175 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $620,781 | BOYAmt |
| EOY | $894,774 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $762,088 | BOYAmt |
| EOY | $933,812 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $25,814,997 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $18,690,672 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $6,383,473 | BOYAmt |
| EOY | $7,124,325 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $11,370,170 | BOYAmt |
| EOY | $13,618,069 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $38,148,822 | BOYAmt |
| EOY | $37,144,519 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $9,560,172 | BOYAmt |
| EOY | $8,817,556 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $965,353 | BOYAmt |
| EOY | $950,459 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $10,525,525 | BOYAmt |
| EOY | $9,768,015 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows SFAS117 | Yes (X) | OrganizationFollowsSFAS117Ind |
Unrestricted Net Assets UnrestrictedNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $26,866,555 | BOYAmt |
| EOY | $26,619,762 | EOYAmt |
Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $756,742 | BOYAmt |
| EOY | $756,742 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $27,623,297 | BOYAmt |
| EOY | $27,376,504 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $38,148,822 | BOYAmt |
| EOY | $37,144,519 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | -$246,793 | ReconcilationRevenueExpnssAmt |
| Other Changes In Net Assets | $0 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (1) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (1) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Medical Research Organization | Yes (X) | MedicalResearchOrganizationInd |
Hospital Name And Address HospitalNameAndAddressGrp
Supported Organization Name SupportedOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | The University of California San Diego | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| City | San Diego | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
Schedule B IRS990ScheduleB
Schedule D IRS990ScheduleD
Buildings BuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $127,911 | OtherCostOrOtherBasisAmt |
| Depreciation | $124,884 | DepreciationAmt |
| Book Value | $3,027 | BookValueAmt |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $7,096,625 | OtherCostOrOtherBasisAmt |
| Depreciation | $3,404,979 | DepreciationAmt |
| Book Value | $3,691,646 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $18,575,461 | OtherCostOrOtherBasisAmt |
| Depreciation | $15,160,809 | DepreciationAmt |
| Book Value | $3,414,652 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $15,000 | OtherCostOrOtherBasisAmt |
| Book Value | $15,000 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $7,124,325 | TotalBookValueLandBuildingsAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $57,724,943 | TotalRevEtcAuditedFinclStmtAmt |
| Revenue Not Reported | $0 | RevenueNotReportedAmt |
| Revenue Subtotal | $57,724,943 | RevenueSubtotalAmt |
| Other Revenues Not Included | $305,173 | OtherRevenuesNotIncludedAmt |
| Revenue Not Reported Fincl Stmt | $305,173 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $58,030,116 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $57,971,736 | TotExpnsEtcAuditedFinclStmtAmt |
| Expenses Not Reported | $0 | ExpensesNotReportedAmt |
| Expenses Subtotal | $57,971,736 | ExpensesSubtotalAmt |
| Other Expenses Not Included | $305,173 | OtherExpensesNotIncludedAmt |
| Expenses Not Rpt Fincl Stmt | $305,173 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $58,276,909 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Part X, Line 2: | The Institute is subject to federal and state income taxes on unrelated business income as defined under IRC Sections 511 through 515. For each of the years ended December 31, 2017 and 2016, taxes are recorded when paid and no provision for income tax has been made. The Institute had no unrecognized tax benefits or liabilities as of December 31, 2017 and 2016. |
| Part XI, Line 4b - Other Adjustments: | Expenses Netted Against Revenue on Audited Financial Statements 305,173. |
| Part XII, Line 4b - Other Adjustments: | Expenses Netted Against Revenue on Audited Financial Statements 305,173. |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (5 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|---|
| South Asia | 0 | 0 | Program services | Research | $185,045 |
| Europe (including Iceland and Greenland) | 0 | 0 | Program services | Research | $462,396 |
| South America | 0 | 0 | Program services | Research | $71,629 |
| East Asia and the Pacific | 0 | 0 | Program services | Research | $14,895 |
| Sub-Saharan Africa | 0 | 0 | Program services | Research | $144,009 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 0 | SubtotalEmployeesCnt |
| Continuation Total Office | 0 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 0 | ContinuationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Subtotal Spent | $877,974 | SubtotalSpentAmt |
| Continuation Spent | $0 | ContinuationSpentAmt |
| Total Spent | $877,974 | TotalSpentAmt |
| Transfer To Foreign Corp | 0 | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | 0 | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | 0 | BoycottCountriesInd |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable
Recipient Business Name RecipientBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | JDRF | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 5665 Oberlin Drive Suite 106 | AddressLine1Txt |
| City | San Diego | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 92121 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Recipient EIN | 231907729 | RecipientEIN |
| IRC Section | 501(c)(3) | IRCSectionDesc |
| Cash Grant | $6,000 | CashGrantAmt |
| Purpose Of Grant | To Cure Type I Diabetes and Promiss Ball 2017. | PurposeOfGrantTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 1 | Total501c3OrgCnt |
| Total Other Org | 0 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Part I, Line 2: | FormAndLineReferenceDesc |
| Explanation | LJI supports certain charities whose mission is inline with our research. This support is not in the form of grants, but rather contributions. Therefore, documentation exists over payment of contributions. Formal monitoring and selections procedures not considered necessary. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | 0 | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (9 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mitchell Kronenberg PhD | ||||||||||||||
| President & CSO | $491,045 | $0 | $0 | $0 | $32,792 | $0 | $40,500 | $0 | $19,015 | $0 | $583,352 | $0 | $0 | $0 |
| Jennifer K Keyes | ||||||||||||||
| CFO | $160,256 | $0 | $0 | $0 | $14,763 | $0 | $26,363 | $0 | $9,562 | $0 | $210,944 | $0 | $0 | $0 |
| Amnon Altman | ||||||||||||||
| Director, Scientific Affairs | $283,954 | $0 | $0 | $0 | $38,006 | $0 | $40,500 | $0 | $22,839 | $0 | $385,299 | $0 | $0 | $0 |
| Stephen Wilson | ||||||||||||||
| EVP, Chief Administrative Officer | $336,122 | $0 | $0 | $0 | $19,400 | $0 | $40,500 | $0 | $33,130 | $0 | $429,152 | $0 | $0 | $0 |
| Hilde Cheroutre | ||||||||||||||
| Division Head/Professor | $274,455 | $0 | $0 | $0 | $4,354 | $0 | $40,500 | $0 | $9,680 | $0 | $328,989 | $0 | $0 | $0 |
| Klaus Ley | ||||||||||||||
| Division Head/Professor | $308,928 | $0 | $0 | $0 | $35,755 | $0 | $40,500 | $0 | $9,661 | $0 | $394,844 | $0 | $0 | $0 |
| Stephen P Schoenberger | ||||||||||||||
| Professor | $288,431 | $0 | $0 | $0 | $19,848 | $0 | $40,500 | $0 | $29,130 | $0 | $377,909 | $0 | $0 | $0 |
| Alessandro Sette | ||||||||||||||
| Center Head/Division Head/Pro | $385,380 | $0 | $0 | $0 | $20,748 | $0 | $40,500 | $0 | $25,594 | $0 | $472,222 | $0 | $0 | $0 |
| Catherine Hedrick | ||||||||||||||
| Professor | $290,803 | $0 | $0 | $0 | $17,477 | $0 | $40,500 | $0 | $17,105 | $0 | $365,885 | $0 | $0 | $0 |
Schedule L IRS990ScheduleL
Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp
Name Of Interested NameOfInterested
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | SEE PART V | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Sharing Of Revenues | 0 | SharingOfRevenuesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Sch L, Part IV, Business Transactions Involving Interested Persons: | FormAndLineReferenceDesc |
| Explanation | (a) Name of Person: Hilde Cheroutre(b) Relationship Between Interested Person and Organization: Spouse of President and CSO (c) Amount of Transaction $278,809(d) Description of Transaction: Full Time Employee(e) Sharing of Organization Revenues? = No(a) Name of Person: Kyowa Kirin Pharmaceutical Research, Inc.(b) Relationship Between Interested Person and Organization:KKR is a Substantial Contributor to the Organization.(c) Amount of Transaction $3,416,575(d) Description of Transaction: Research Funding, Facility Rent, Cost Reimbursements (e) Sharing of Organization Revenues? = No | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (7 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Form 990, Part III, Line 4a; | The Institute was recently ranked among the top five organizations with the greatest research impact in immunology worldwide by the rating agency Thomson-Reuters. In addition, four of its scientists are among the most highly cited immunologists in the world-a distinction held by less than half of one percent of all publishing scientists. One of them, Prof. Dr. Shane Crotty's made the list for the second year in a row in recognition of his pioneering studies on vaccine-related immunology. Illustrating the caliber and impact of LJI's researchers, Dr. Alessandro Sette's team has been named Best Academic Research Team as part of the 10th Vaccine Industry Excellence Awards at the World Vaccine Congress 2017. The ViE Awards celebrate the outstanding contributions and achievements of leaders who continually set standards of excellence and advocacy in vaccine development. Dr. Klaus Ley has been selected as the 2017 winner of the Eugene M. Landis Award, the Microcirculatory Society's top honor, in recognition of his pioneering work in vascular biology and microcirculation. In 2017, La Jolla Institute launched the Center for Asthma Prevention and Treatment dedicated to understanding, treating and solving the problem of asthma. A joint endeavor between LJI and UC San Diego Health, the center will bring together patients, clinicians and researchers to accelerate the development of individualized asthma treatments based on patient-specific disease markers. The wide range of expertise coming together at the Center for Asthma Prevention and Treatment made an immediate impact. It allowed a team of physicians, scientists and bioinformaticians affiliated with the center to successfully compete for an $8.5 million grant to establish one of only ten PrecISE Network Clinical Centers nationwide. The PrecISE Network is an initiative funded by the National Institutes of Health/National Heart, Lung and Blood Institute, to advance precision medicine for patients with severe and exacerbation-prone asthma. 2017 Notable Research Results In 2017, LJI research teams made discoveries meriting publication in leading peer-reviewed scientific journals 135 papers in all, continuing a trend of very high productivity. 40 of them appeared in high impact journals, which is a measure of the research's pioneering nature and influence. Together, they illustrate the range and power of immunology research, the caliber of LJI's faculty and their impact on a broad group of human health issues. Some of the highlights among papers published in 2017 include: Dr. Alessandro Sette and his collaborators found the first direct evidence that autoimmunity--in which the immune system attacks the body's own tissues--plays a role in Parkinson's disease, the neurodegenerative movement disorder. The findings raise the possibility that the death of neurons in Parkinson's could be prevented by therapies that dampen the immune response. The idea that a malfunctioning immune system contributes to Parkinson's dates back almost 100 years. But until now, no one had been able to connect the dots. Plus, scientists long thought that neurons were protected from autoimmune attacks. Dr. Sette's findings show that two fragments of alpha-synuclein, a protein that accumulates in the brain cells of people with Parkinson's, can activate the T cells involved in autoimmune attacks. The study was published today in the June edition of Nature. Dr. Pandurangan Vijayanand and his team demonstrated that tumor immune fitness determines survival of lung cancer patients. In recent years, immunotherapy, a new form of cancer therapy that rouses the immune system to attack tumor cells, has captivated the public's imagination. When it works, the results are breathtaking. But more often than not it doesn't, and scientists still don't know why. Publishing in the June 2017 issue of Nature Immunology, Dr. Vijayanand's team identified a subpopulation of T cells in tumors known as tissue-resident memory T cells (TRM) as an important distinguishing factor between cancer patients whose immune system mounts an effective anti-tumor response and those who are unable to do so. Their finding emerged from the first large-scale effort to profile the gene expression patterns of cytotoxic T cells isolated directly from patients' tumors. Dr. Klaus Ley's lab provided new insight into how neutrophils, the immune system's EMTs, spend most of their lives racing through the bloodstream constantly on the lookout for bacteria and other foreign invaders. Once they arrive at infiltrated tissues, they halt on a dime and slip through the vessel wall to reach the site of infection. Dr. Klaus Ley and his colleagues developed a sophisticated intra-vital imaging method that allowed them to watch in real time how neutrophils control their speed as they roll along the walls of blood vessels. The dramatic, real-time footage shows in great detail how neutrophils throw out tube-like tethers to anchor themselves to avoid being swept away by blood rushing by at high speed. As neutrophils gently roll along, tether after tether is peeled loose and slung forward like a lasso to gain new leverage, slowing them down enough to exit the blood vessel. A study by Dr. Shane Crotty and his collaborators established important benchmarks for HIV vaccine candidates. The development of a vaccine that protects against HIV infections has proven extraordinarily difficult. One of the reasons is that nave precursor B cells that can give rise to mature B cells producing broadly neutralizing antibodies-a requirement for a successful antibody-based HIV vaccine-are considered to be exceedingly rare within the average human. Publishing in the December 201 issue of the journal Immunity, Dr. Crotty and team were able to show that despite their low frequency these B cell precursors can be successfully primed to prevail over their B cell competitors under the right conditions. Earlier studies had detected these B cells in most humans but at very low frequencies, about one in a million and it had been unclear whether that was enough to elicit an effective immune response. By providing an answer, the current study closes the knowledge gap about competition between different immune responses and establishes defined benchmarks vaccine candidates should be compared against for consideration before they are put into clinical trials. Dr. Klaus Ley successfully mirrored the breadth of genetic and immunological diversity found in the human population in the lab by using a panel of about 100 different inbred mouse strains instead of just one. The new approach successfully replicates natural human immune variation in the lab and allowed Dr. Ley and his team to identify a molecular fingerprint that successfully predicted individual people's susceptibility to inflammatory disease as well as survival of patients with certain cancers. Traditionally, researchers have relied on genetically identically mouse strains to gain insight into the complex world of human diseases while reducing what is known as experimental noise. But in contrast to these mice, not two people are genetically alike. As a direct result many promising drug candidates fizzled in the face of human genetic diversity. Competitive Research Grant Funding & Research Awards & Distinctions In 2017, La Jolla Institute scientists continued to attract increasing numbers of competitively awarded research grants attesting to the high level of research productivity present at the Institute. One example is Dr. Catherine (Lynn) Hedrick, Ph.D., a Professor in the Division of Inflammation Biology, who has been awarded a five-year, $13 million grant by the National Institutes of Health to lead a collaborative research program project to study how functional changes in immune cells contribute to atherosclerosis. The end goal of the study is to identify novel therapeutic strategies targeting immune cell function to reduce cardiovascular disease. |
| During 2017, LJI scientists worked with the support of 152 grants, contract | and fellowships. The granting institutions included: National Institutes of Health, Boston Children's Hospital, Benaroya Research Institute at Virginia Mason, University of California Berkeley, Case Western University, Cedars Sinai Medical Center, Dana-Farber Cancer Institute, Albert Einstein College of Medicine, Emory University, University of Georgia, University of Wisconsin, Ichan School of Medicine at Mount Sinai, Sanford Burnham Prebys Medical Discovery Institute, The Scripps Research Institute, University of Florida, University of Alabama at Birmingham, University of California Los Angeles, University of California San Diego, University of North Carolina, University of Washington, University of Arizona, EU/European Commission, Lurie Children's Hospital of Chicago, American Heart Association, Arthritis National Research Foundation, Crohn's and Colitis Foundation of America, Cancer Research Institute, Immune Deficiency Foundation, Jane Coffin Childs Memorial Fund for Medical Research, Jeffrey Modell Foundation, Johns Hopkins University, Leukemia and Lymphoma Society, The Michael J. Fox Foundation, National Parkinson's Foundation, Oregon Health Science University, The Pew Charitable Trusts, Rady Children's Hospital - San Diego, Thrasher Research Fund, University of Cape Town, University of Miami, American Lung Association, Human Vaccines Project, and the Vasculitis Foundation. With new and recurring grant support, the Institute received more than $44 million in research funding in 2017, which is supplemented by corporate funding sources as well as philanthropic support. |
| Form 990, Part VI, Section A, line 2 | Mitchell Kronenberg, Ph.D. and Hilde Cheroutre have a family relationship. |
| Form 990, Part VI, Section B, line 11b | In accordance with written Institute Policy, a draft of Form 990 is provided to all Board Members for their review and comment approximately 10 days prior to filing. This provides an opportunity for members of the Board to ask questions and obtain additional information. Comments and suggested changes to the draft are incorporated into the final version of Form 990. |
| Form 990, Part VI, Section B, line 12c | The Institute administers three separate conflict of interest policies applying to 1) The Board of Directors, 2) Faculty and Senior Administration, and 3) An investigator financial conflict of interest policy required under National Institutes of Health Regulations. The Institute regularly and consistently monitors and enforces these policies in accordance with written procedures, which include the completion of disclosure forms by covered individuals, evaluation of completed forms by a designated conflict review officer, and as necessary, further evaluation and determination by a designated conflict review committee. If a conflict is determined, a management plan is designed and monitored for the specific situation. Such plan may require the covered individual to eliminate the conflict. |
| Form 990, Part VI, Section B, line 15 | Compensation decisions for the institute's CEO and other key employees are Made annually. Adjustments, if any, typically take effect on a January 1st Cycle. For these purposes, the institute's Human Resources Department Obtains relevant market comparability data for each position on an annual Basis. The institute also periodically engages an independent compensation Consulting firm to perform compensation studies for key individuals and to Evaluate the institute's executive compensation and benefits programs for Reasonableness. In accordance with its charter, the compensation committee Of the board of directors reviews and discusses this information, and the Performance of the institute's CEO and key employees, and formulates Recommended compensation actions to the full board of directors. The board Of directors reviews these recommendations and related information in Deciding compensation levels for each position. |
| Form 990, Part VI, Section C, line 19 | The Institute makes its governing documents, Conflict of Interest Policy, and Financial Statements available to the public upon request. Summarized Financial data is also made available as part of the Institute's Annual Report, which is widely distributed, and can be downloaded from the Institute's web site. |